Department of Medicine, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032, USA.
Endocrinology. 2010 Mar;151(3):1002-9. doi: 10.1210/en.2009-0853. Epub 2010 Jan 7.
Hypothalamic proopiomelanocortin (POMC)-derived MSH peptides and the melanocortin receptor antagonist, agouti-related protein (AgRP), interact to regulate energy balance. Both POMC and AgRP neurons express estrogen receptors, but little is known about estrogen regulation of the melanocortin system in the primate. We have therefore examined the effects of physiological doses of estradiol (E2) on POMC and AgRP in lumbar cerebrospinal fluid (CSF) of ovariectomized monkeys. POMC prohormone was measured by ELISA. AgRP was measured by RIA (sensitive for the more biologically active C-terminal AgRP(83-132) but also detects full-length AgRP) and by ELISA (measures primarily full length AgRP). In the first experiment, 14 animals were studied before and after 3 wk of E2. CSF POMC did not change, but AgRP(RIA) decreased from 7.9 +/- 1.2 to 4.7 +/- 1.2 fmol/ml after E2 (P = 0.03) and the POMC/AgRP(RIA) ratio increased from 4.2 +/- 0.89 to 6.8 +/- 1.04 (P = 0.04). AgRP(ELISA) did not change, but the ratio of AgRP(RIA) compared with AgRP(ELISA) was reduced after E2 (P = 0.02). In the second experiment, 11 animals were studied after 6 wk of E2, and similar changes were noted. The degree of AgRP(RIA) suppression with E2 was inversely related to body mass index (r = 0.569; P = 0.03). These results show for the first time that E2 suppresses AgRP(C-terminal) in CSF, increases the POMC to AgRP ratio, and may decrease AgRP processing, thus leading to increased melanocortin signaling. Furthermore, obesity was associated with resistance to the suppressive effects of E2 on AgRP, analogous to what is seen with obesity and leptin resistance.
下丘脑前阿黑皮素原(POMC)衍生的黑色素细胞刺激素肽和黑色素皮质素受体拮抗剂,肥胖相关蛋白(AgRP)相互作用以调节能量平衡。POMC 和 AgRP 神经元均表达雌激素受体,但关于雌激素对灵长类动物黑色素系统的调节知之甚少。因此,我们研究了生理剂量的雌二醇(E2)对去卵巢猴腰椎脑脊液(CSF)中 POMC 和 AgRP 的影响。通过 ELISA 测定 POMC 前激素。通过 RIA(对更具生物活性的 C 端 AgRP(83-132)敏感,但也检测全长 AgRP)和 ELISA(主要测量全长 AgRP)测定 AgRP。在第一个实验中,研究了 14 只动物在 E2 治疗前 3 周和治疗后 3 周的情况。CSF POMC 没有变化,但 E2 后 AgRP(RIA)从 7.9±1.2 降至 4.7±1.2 fmol/ml(P=0.03),POMC/AgRP(RIA)比值从 4.2±0.89 增加到 6.8±1.04(P=0.04)。AgRP(ELISA)没有变化,但 E2 后 AgRP(RIA)与 AgRP(ELISA)的比值降低(P=0.02)。在第二个实验中,研究了 11 只动物在 E2 治疗 6 周后的情况,也观察到类似的变化。E2 抑制 AgRP(RIA)的程度与体重指数呈负相关(r=0.569;P=0.03)。这些结果首次表明,E2 抑制 CSF 中的 AgRP(C 端),增加 POMC 与 AgRP 的比值,并可能减少 AgRP 加工,从而导致黑色素皮质素信号增加。此外,肥胖与 E2 对 AgRP 的抑制作用的抗性有关,类似于肥胖和瘦素抵抗。